Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oregon DHEA bill

This article was originally published in The Tan Sheet

Executive Summary

School employees would be prohibited from knowingly endorsing or suggesting the ingestion of any performance-enhancing supplement to students under a bill recently introduced by Oregon Senate President Peter Courtney, D-Salem. The legislation, SB 517, also contains provisions that would partner the Department of Education with voluntary organizations to develop educational programs for students to prevent the use of steroids and performance-enhancing supplements. The Act is declared an "emergency" measure and would punish violators with three months imprisonment or $500 or both. The bill passed the Senate Education and General Government subcommittee on March 13, according to Courtney's staff. Sen. Courtney introduced a similar bill in 2005. It passed the Senate but was defeated in the House...

You may also be interested in...

Alabama bill targets andro, DHEA

The sale of dietary supplements containing androstanedione, dehydroepiandrosterone or ephedrine alkaloids to consumers under 18 years of age would be prohibited under a bill recently introduced in the Alabama state legislature. The proposal requires that sellers obtain valid identification from purchasers, and makes violation of the law a Class A misdemeanor. HB 356, sponsored by Rep. Tommy Sherer (D) and House Majority leader Ken Guin (D), was referred to the Health Committee March 15. In other DHEA-related legislative activity, an Oregon state bill would bar school employees from endorsing use of performance-enhancing supplements by students, while a federal bill by Sen. Charles Grassley, R-Iowa, would list DHEA as an anabolic steroid under the Controlled Substances Act (1"The Tan Sheet" March 19, 2007, In Brief and 2"The Tan Sheet" March 12, 2007, In Brief)...

Legend Biotech CEO Ying Huang On Moving Fast In the BCMA CAR-T Race

Ying Huang was named CEO as his predecessor came under investigation in China and as partner Janssen was getting closer to seeking US FDA approval for its lead CAR-T therapy.

Brazil Authorizes Oxford/AZ and Sinovac Vaccines

In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts